BriaCell Therapeutics Corp. (BCTX) vs Baird Medical Investment Holdings Limited (BDMD)
A side-by-side comparison of BriaCell Therapeutics Corp. and Baird Medical Investment Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BCTX
BriaCell Therapeutics Corp.
$4.02HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
BDMD
Baird Medical Investment Holdings Limited
$0.78HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BCTX vs BDMD
growth of $100 · dividends reinvested · last 5yBCTX -99.7% (-68.0%/yr)BDMD -92.3% (-40.1%/yr)BDMD compounded faster over this window
Log scale — wide-divergence pair
BCTX BDMD
BCTX vs BDMD: by the numbers
- •BCTX is the larger company ($35M vs $33M market cap).
- •Both run net losses; BCTX's is the smaller (0.00% vs -121.04% net margin).
Metrics side by side
Valuation
| Metric | BCTX | BDMD |
|---|---|---|
| Forward P/E | N/A | 9.75 |
| P/B ratio | 1.45 | 0.95 |
Profitability
| Metric | BCTX | BDMD |
|---|---|---|
| Gross margin | 0.00% | 83.79% |
| Operating margin | 0.00% | -113.31% |
| Net margin | 0.00% | -121.04% |
| ROE | -154.06% | -86.96% |
| ROIC | -164.58% | -50.66% |
Growth (annualized)
| Metric | BCTX | BDMD |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 4.46% |
| Total return CAGR (5Y) | -67.32% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.